7TM Pharma is a biotech company focusing on discovery and development of new drugs targeting 7TM receptors. 7TM Pharma’s primary therapeutic area is metabolic diseases, including obesity, diabetes and cardiovascular diseases. According to the WHO, there are more than 400 million clinically obese people worldwide, and the number is growing rapidly. In spite of this, there are only few approved therapies for obesity with limited effect.

The basis for 7TM Pharma’s drug discovery is thorough and comprehensive knowledge about 7TM receptors and their structures, which the company uses in the design of new potential drugs. In recent years, the company has established a broad pipeline of research and development programs based on in-house drug discovery and development.